JERROLD DUANE DOTSON - 01 Mar 2022 Form 4 Insider Report for VistaGen Therapeutics, Inc. (VTGN)

Role
VP, CFO AND SECRETARY
Signature
/s/ Jerrold D. Dotson
Issuer symbol
VTGN
Transactions as of
01 Mar 2022
Net transactions value
$0
Form type
4
Filing time
03 Mar 2022, 15:17:16 UTC
Previous filing
12 Jan 2022
Next filing
15 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VTGN Stock Option (Right to Buy) Award $0 +150,000 $0.000000 150,000 01 Mar 2022 Common Stock 150,000 $1.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan. Twenty-five percent (25%) of the total number of shares vest immediately on March 1, 2022 (the "Vesting Start Date") and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years after the Vesting Start Date.